The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2015

Filed:

Oct. 27, 2011
Applicants:

Toshiaki Ohtsuka, Saitama, JP;

Takeshi Takizawa, Tokyo, JP;

Akiko Oguni, Tokyo, JP;

Tatsuji Matsuoka, Tokyo, JP;

Hiroko Yoshida, Tokyo, JP;

Yumi Matsui, Tokyo, JP;

Inventors:

Toshiaki Ohtsuka, Saitama, JP;

Takeshi Takizawa, Tokyo, JP;

Akiko Oguni, Tokyo, JP;

Tatsuji Matsuoka, Tokyo, JP;

Hiroko Yoshida, Tokyo, JP;

Yumi Matsui, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C12N 5/10 (2006.01); C12N 15/13 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 14/705 (2006.01); A61K 31/337 (2006.01); A61K 31/4745 (2006.01); A61K 31/475 (2006.01); A61K 31/555 (2006.01); A61K 31/439 (2006.01); A61K 31/4545 (2006.01); A61K 31/513 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61K 31/337 (2013.01); A61K 31/439 (2013.01); A61K 31/4545 (2013.01); A61K 31/475 (2013.01); A61K 31/4745 (2013.01); A61K 31/513 (2013.01); A61K 31/555 (2013.01); A61K 39/39558 (2013.01); C07K 14/70578 (2013.01); C07K 16/2878 (2013.01); A61K 2039/505 (2013.01); C07K 2299/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/55 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01);
Abstract

The present invention relates to an antibody which has a therapeutic effect on cancer, an autoimmune disease, or an inflammatory disease. That is, the present invention relates to an antibody which exhibits a cytotoxic activity against death domain-containing receptor-expressing cells through apoptosis. [Object] An object of the invention is to provide a pharmaceutical having a therapeutic effect on cancer. [Means for Resolution] A novel anti-DR5 antibody capable of inducing apoptosis in cells has more potent cytotoxic activity than currently available anti-DR5 antibodies.


Find Patent Forward Citations

Loading…